Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms esagonowsky Fri, 02/04/2022 – 10:34
Category: Uncategorized
Regeneron projects no near-term sales of its blockbuster COVID-19 antibody given FDA action to ground it kdunleavy Fri, […]
Eli Lilly’s Trulicity dethrones Dupixent, taking January’s TV ad spending crown badams Fri, 02/04/2022 – 08:17
Sanofi’s Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter fkansteiner […]
World Cancer Day takes place every year on February 04, and this year is the 22nd time. The […]
A new study, led by researchers at Uppsala University, shows that all individual patients suffering from severe COVID-19 […]
MHH Radiology puts computer tomograph with integrated laser navigation into operation
Health and care services exist to improve wellbeing through interventions that seek to prevent ill health, protect from […]
bmj;376/feb04_8/o290/FAF1faBorn Barbara Lewis in Walthamstow, to parents who had been told that they’d never have children, my mother […]
